Hypertensive patients with greater genetic risk respond less effectively to treatment and are more likely to be treatment resistant in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)
Introduction and Aims: Treatment-resistant hypertension (RHTN) patients have increased cardiovascular risks, and it is believed that RHTN may have genetic causes. It is also hypothesised that genetics may explain the inter-individual variability in antihypertensive drug response of patients.Our late...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | Clinical Medicine |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1470211825001253 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|